1. Drug Treatment
For secondary splenic hyperfunction, active treatment for the primary disease is needed. For example, when the infection is controlled, leukemia is relieved, and portal hypertension is reduced, splenic hyperfunction can usually be relieved to some extent. However, for splenic enlargement that is still difficult to control after non-surgical treatment, because there is no specific drug that can inhibit it, once severe anemia, thrombocytopenia leads to serious bleeding, and so on, surgical or interventional treatment is the preferred method. Generally including splenectomy, partial splenectomy, interventional treatment (currently mainly splenic artery embolism), among which splenectomy has the most direct and definite efficacy.
2. Surgical Treatment
In addition to splenectomy for primary splenic hyperfunction and splenic diseases such as splenic tumors, splenectomy for splenic hyperfunction needs to meet strict indications. The main diseases include the following:
(1) Congestive splenomegaly caused by portal hypertension;
(2) Splenomegaly caused by infectious diseases, such as splenic abscess, tuberculosis;
(3) Hereditary spherocytosis, autoimmune hemolytic anemia, and others;
(4) Primary thrombocytopenic purpura patients who are ineffective with medical treatment;
(5) Chronic aplastic anemia;
(6) Patients with macrocytic anemia caused by chronic myelocytic leukemia;
(7) Gaucher's disease;
(8) Some Hodgkin's disease.
It needs to be emphasized especially that splenectomy or splenic artery embolism can only relieve the impact of the spleen on the blood system, but cannot cure the primary disease. Especially for some blood system diseases such as splenic hyperfunction in red and white blood diseases, which can alleviate the symptoms of the disease itself, the hematopoietic function of patients with chronic myelofibrosis can be transferred to the spleen when the bone marrow becomes hard, or the liver lesions of Gaucher's disease may worsen after splenectomy, and splenectomy may be more harmful than beneficial.
For splenic hyperfunction caused by other etiologies, the choice of treatment needs to fully refer to the professional opinions of hematology, rheumatology, and infectious diseases, make a full assessment of the impact on splenectomy, and then decide whether to perform surgical treatment.
3. Interventional Treatment
For patients suitable for splenectomy, whether their own conditions are feasible and whether there are surgical contraindications also need to be evaluated in a regular hospital specialty department. If surgical treatment cannot be tolerated, minimally invasive interventional treatment is a suitable option.